Analysis of the Promoter Region of Human Dopamine Receptor D1

被引：2

作者：

Wu, Xue ^{[1
]}

Xu, Feng-ling ^{[1
]}

Wang, Bao-jie ^{[1
]}

Yao, Jun ^{[1
]}

机构：

[1] China Med Univ, Sch Forens Med, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China

来源：

JOURNAL OF MOLECULAR NEUROSCIENCE | 2018年 / 65卷 / 04期

基金：

中国国家自然科学基金;

关键词：

DRD1; Transcriptional regulator; Promoter; Neuropsychiatric disorder; GENE; SCHIZOPHRENIA; DRD1; POLYMORPHISMS; TRANSCRIPTION; ASSOCIATION; DEPENDENCE; DISORDER; DISEASE;

D O I：

10.1007/s12031-018-1116-0

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Dysregulation of dopamine receptor D1 (DRD1) is involved in multiple neuropsychiatric disorders. The 5' regulatory region of DRD1 has not been characterized fully. We applied the luciferase assay and the electrophoretic mobility shift assay to explore the activity of the 5' regulatory region of DRD1 in SH-SY5Y and 293T cells. We found that the promoter region of DRD1 corresponded to positions - 1250 to + 250 in the DNA sequence, and the putative core promoter region was from - 113 to + 250 (transcriptional start site of exon, +1). The sequence 5'-gggacgcgcgggcggggtgggctgtgccccgcgggaaccccgccggcctgtgcgcttgctg-3' was identified as a possible transcription factor-binding domain. Further research is warranted to explore the function of the 5' regulatory region of DRD1.

引用

下载

页码：438 / 443

页数：6

共 50 条

[31] The Effect of Dopamine D1 Receptor on Cognitive Performance
Roussos, Panos
BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 4S - 4S
[32] Dopamine D1 receptor on cultured Muller cells
Minei, R
Wakakura, M
Mashimo, K
NEURAL BASIS OF EARLY VISION, 2003, 11 : 147 - 147
[33] Advances in Dopamine D1 Receptor Ligands for Neurotherapeutics
Felsing, Daniel E.
Jain, Manish K.
Allen, John A.
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (16) : 1365 - 1380
[34] Structural insights into the human D1 and D2 dopamine receptor signaling complexes
Zhuang, Youwen
Xu, Peiyu
Mao, Chunyou
Wang, Lei
Krumm, Brian
Zhou, X. Edward
Huang, Sijie
Liu, Heng
Cheng, Xi
Huang, Xi-Ping
Shen, Dan-Dan
Xu, Tinghai
Liu, Yong-Feng
Wang, Yue
Guo, Jia
Jiang, Yi
Jiang, Hualiang
Melcher, Karsten
Roth, Bryan L.
Zhang, Yan
Zhang, Cheng
Xu, H. Eric
CELL, 2021, 184 (04) : 931 - +
[35] Dopamine D1 receptor agonists as antiparkinson drugs
Mailman, RB
Nichols, DE
TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (07) : 255 - 256
[36] ARE D1 DOPAMINE RECEPTOR AGONISTS POTENTIAL ANTIDEPRESSANTS
SERRA, G
COLLU, M
DAQUILA, P
PANI, L
GESSA, GL
PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1988, 20 (12): : 1121 - 1122
[37] Golfα mediates dopamine D1 receptor signaling
Zhuang, XX
Belluscio, L
Hen, R
JOURNAL OF NEUROSCIENCE, 2000, 20 (16): : art. no. - RC91
[38] Cloning of hemicentrotus pulcherrimus dopamine receptor D1
Jinnai, Takayuki
Nikaido, Masataka
Suyemitsu, Takashi
ZOOLOGICAL SCIENCE, 2005, 22 (12) : 1472 - 1472
[39] Characterization of the dopamine D1 receptor transgenic mice
Dracheva, S
Haroutunian, V
Grandy, DK
Sealfon, SC
BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 70S - 70S
[40] HIGHLIGHTS OF D1 DOPAMINE RECEPTOR ANTAGONIST RESEARCH
BARNETT, A
MCQUADE, RD
TEDFORD, C
NEUROCHEMISTRY INTERNATIONAL, 1992, 20 : S119 - S122

← 1 2 3 4 5 →